Investigating the mechanism of action of Danhong injection and its components against myocardial ischemia-reperfusion injury

Abstract

Objective: The surgical treatment of myocardial infarction often causes myocardial ischemia-reperfusion injury (MI/RI). Danhong injection (DHI) has curative effects on coronary heart disease and angina pectoris. However, its therapeutic effects on MI/RI still require further validation. This study aims to investigate the components involved and mechanism of action of DHI against MI/RI.
Methods: Primary metabolites (PM) and secondary metabolites (SM) were isolated from DHI. We established a rat model of MI/RI by administering PM, SM, and DHI. Cardiac morphology and functional parameters were evaluated using cardiac ultrasound. The metabolic effects of PM, SM, and DHI in the serum and myocardial tissue on MI/RI were investigated using ¹hydrogen-nuclear magnetic resonance.
Results: Our study showed that DHI, PM, and SM could improve cardiac function by correcting the dilated cardiac structure, alleviating inflammation by downregulating complement C2 expression, reducing reactive oxygen species (ROS) production by upregulating cyclooxygenase expression, and restoring normal energy supply by inhibiting fatty acid metabolism and stimulating glycometabolism. In addition, DHI and SM could attenuate the calcium overload and trigger an inflammatory response and oxidative stress by downregulating Ca²⁺/calmodulin-dependent protein kinase II expression.
Conclusions: This study suggests that DHI and its components exerts resistance against MI/RI by ameliorating cardiac dysfunction, energy metabolism, and oxidative stress.

Keywords

Danhong injection / Myocardial ischemia-reperfusion injury / Primary metabolites / Secondary metabolites

References

[[1]] Pickersgill SJ, Msemburi WT, Cobb L, et al.Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes. Nat Med2022;28(8):1693-1699.

[[2]] van der Schoot GGF, Anthonio RL, Jessurun GAJ. Acute myocardial infarction in adolescents: reappraisal of underlying mechanisms. Neth Heart J 2020;28(6):301-308.

[[3]] Gulati R, Behfar A, Narula J, et al. Acute Myocardial infarction in young individuals. Mayo Clin Proc 2020;95(1):136-156.

[[4]] Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg 2021;60(4):727-800.

[[5]] Collet C, Capodanno D, Onuma Y, et al. Left main coronary artery disease: pathophysiology, diagnosis, and treatment. Nat Rev Cardiol 2018;15(6):321-331.

[[6]] Smilowitz NR, Alviar CL, Katz SD, et al. Coronary artery bypass grafting versus percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock. Am Heart J 2020;226:255-263.

[[7]] Del Re DP. Mechanisms of ischemic heart injury. Cells 2022;11(9):1384.

[[8]] Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest 2013;123(1):92-100.

[[9]] Pell VR, Chouchani ET, Frezza C, et al. Succinate metabolism: a new therapeutic target for myocardial reperfusion injury. Cardiovasc Res 2016;111(2):134-141.

[[10]] Wallert M, Ziegler M, Wang X, et al. α-Tocopherol preserves cardiac function by reducing oxidative stress and inflammation in ischemia/reperfusion injury. Redox Biol 2019;26:101292.

[[11]] Wang R, Wang M, He S, et al. Targeting calcium homeostasis in myocardial ischemia/reperfusion injury: an overview of regulatory mechanisms and therapeutic reagents. Front Pharmacol 2020;11:872.

[[12]] Jung I-S, Lee S-H, Yang M-K, et al. Cardioprotective effects of the novel Na+/H+ exchanger-1 inhibitor KR-32560 in a perfused rat heart model of global ischemia and reperfusion: involvement of the Akt-GSK-3beta cell survival pathway and antioxidant enzyme. Arch Pharm Res 2010;33(8):1241-1251.

[[13]] Sandanger O, Ranheim T, Vinge LE, et al. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Cardiovasc Res 2013;99(1):164-174.

[[14]] Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 2014;94(3):909-950.

[[15]] Li Y, Ma Y, Dang Q-Y, et al. Assessment of mitochondrial dysfunction and implications in cardiovascular disorders. Life Sci 2022;306:120834.

[[16]] Cadenas S. ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection. Free Radic Biol Med. 2018;117:76-89.

[[17]] Neginskaya MA, Pavlov EV, Sheu S-S. Electrophysiological properties of the mitochondrial permeability transition pores: channel diversity and disease implication. Biochim Biophys Acta Bioenerg 2021;1862(3):148357.

[[18]] Feng X, Li Y, Wang Y, et al. Danhong injection in cardiovascular and cerebrovascular diseases: pharmacological actions, molecular mechanisms, and therapeutic potential. Pharmacol Res 2019;139:62-75.

[[19]] He S, Chen R, Peng L, et al. Differential action of pro-angiogenic and anti-angiogenic components of Danhong injection in ischemic vascular disease or tumor models. Chin Med 2022;17(1):4.

[[20]] Hu Z, Wang H, Fan G, et al. Danhong injection mobilizes endothelial progenitor cells to repair vascular endothelium injury via upregulating the expression of Akt, eNOS and MMP-9. Phytomedicine 2019;61:152850.

[[21]] Fan H, Li M, Yu L, et al. Effects of Danhong injection on platelet aggregation in hyperlipidemia rats. J Ethnopharmacol 2018;212:67-73.

[[22]] Feng C, Wan H, Zhang Y, et al. Neuroprotective effect of Danhong injection on cerebral ischemia-reperfusion injury in rats by activation of the PI3K-Akt pathway. Front Pharmacol 2020;11:298.

[[23]] Du H, Li C, Wang Z, et al. Effects of Danhong injection on dyslipidemia and cholesterol metabolism in high-fat diets fed rats. J Ethnopharmacol 2021;274:114058.

[[24]] Yeo HJ, Lim S-Y, Park CH, et al. Metabolic analyses and evaluation of antioxidant activity in purple kohlrabi sprouts after exposed to UVB radiation. Antioxidants (Basel) 2022;11(8):1443.

[[25]] Xu L, peng SZ, Bo T, et al. Rapid quantitation and identification of the chemical constituents in Danhong injection by liquid chromatography coupled with orbitrap mass spectrometry. J Chromatogr A 2019;1606:460378.

[[26]] He S, Guo H, Zhao T, et al. A defined combination of four active principles from the Danhong injection is necessary and sufficient to accelerate EPC-mediated vascular repair and local angiogenesis. Front Pharmacol 2019;10:1080.

[[27]] Du G, Song J, Du L, et al. Chemical and pharmacological research on the polyphenol acids isolated from Danshen: a review of salvianolic acids. Adv Pharmacol 2020;87:1-41.

[[28]] Ye J, Wang R, Wang M, et al. Hydroxysafflor yellow a ameliorates myocardial ischemia/reperfusion injury by suppressing calcium overload and apoptosis. Oxid Med Cell Longev 2021;2021:6643615.

[[29]] Chen JR, Wei J, Wang LY, et al. Cardioprotection against ischemia/reperfusion injury by QiShenYiQi Pill® via ameliorate of multiple mitochondrial dysfunctions. Drug Des Devel Ther 2015;9:3051-3066.

[[30]] Nicholson JK, Buckingham MJ, Sadler PJ. High resolution 1H n.m.r. studies of vertebrate blood and plasma. Biochem J 1983;211(3):605-615.

[[31]] Liu J, Li D-D, Dong W, et al. Detection of an anti-angina therapeutic module in the effective population treated by a multi-target drug Danhong injection: a randomized trial. Signal Transduct Target Ther 2021;6(1):329.

[[32]] Chen L, Fu G, Hua Q, et al. Efficacy of add-on Danhong injection in patients with unstable angina pectoris: a double-blind, randomized, placebo-controlled, multicenter clinical trial. J Ethnopharmacol 2022;284:114794.

[[33]] Liu S, Wang K, Duan X, et al. Efficacy of Danshen class injection in the treatment of acute cerebral infarction: a Bayesian network meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med 2019;2019:5814749.

[[34]] Tang Y, Wa Q, Peng L, et al. Salvianolic acid B suppresses ER stress-induced NLRP3 inflammasome and pyroptosis via the AMPK/FoxO4 and Syndecan-4/Rac1 signaling pathways in human endothelial progenitor cells. Oxid Med Cell Longev 2022;2022:8332825.

[[35]] Lu B, Li J, Gui M, et al. Salvianolic acid B inhibits myocardial I/R-induced ROS generation and cell apoptosis by regulating the TRIM8/GPX1 pathway. Pharm Biol 2022;60(1):1458-1468.

[[36]] Zhang M, Wei L, Xie S, et al. Activation of Nrf2 by lithospermic acid ameliorates myocardial ischemia and reperfusion injury by promoting phosphorylation of AMP-activated protein kinase α (AMPKα). Front Pharmacol 2021;12:794982.

[[37]] Marinho S, Illanes M, Ávila-Román J, et al. Anti-inflammatory effects of rosmarinic acid-loaded nanovesicles in acute colitis through modulation of NLRP3 inflammasome. Biomolecules 2021;11(2):162.

[[38]] Ling Y, Jin L, Ma Q, et al. Salvianolic acid A alleviated inflammatory response mediated by microglia through inhibiting the activation of TLR2/4 in acute cerebral ischemia-reperfusion. Phytomedicine 2021;87:153569.

[[39]] Wan Y-J, Wang Y-H, Guo Q, et al. Protocatechualdehyde protects oxygen-glucose deprivation/reoxygenation-induced myocardial injury via inhibiting PERK/ATF6α/IRE1α pathway. Eur J Pharmacol 2021;891:173723.

[[40]] Konstam MA, Kramer DG, Patel AR, et al. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging 2011;4(1):98-108.

[[41]] Chen J, Cao W, Asare PF, et al. Amelioration of cardiac dysfunction and ventricular remodeling after myocardial infarction by Danhong injection are critically contributed by anti-TGF-β-mediated fibrosis and angiogenesis mechanisms. J Ethnopharmacol 2016;194:559-570.

[[42]] Chen C-L, Zhang L, Jin Z, et al. Mitochondrial redox regulation and myocardial ischemia-reperfusion injury. Am J Physiol Cell Physiol 2022;322(1):C12-C23.

[[43]] Trujillo-Rangel WA, García-Valdés L, Méndez-Del Villar M, et al. Therapeutic targets for regulating oxidative damage induced by ischemia-reperfusion injury: a study from a pharmacological perspective. Oxid Med Cell Longev 2022;2022:8624318.

[[44]] Matsushima S, Sadoshima J. Yin and Yang of NADPH oxidases in myocardial ischemia-reperfusion. Antioxidants (Basel) 2022;11(6):1069.

[[45]] Kulawiak B, Bednarczyk P, Szewczyk A. Multidimensional regulation of cardiac mitochondrial potassium channels. Cells 2021;10(6):1554.

[[46]] Xia H, Zahra A, Jia M, et al. Na+/H+ exchanger 1, a potential therapeutic drug target for cardiac hypertrophy and heart failure. Pharmaceuticals (Basel) 2022;15(7):875.

[[47]] Liu H, Cala PM, Anderson SE. Na/H exchange inhibition protects newborn heart from ischemia/reperfusion injury by limiting Na+-dependent Ca2+ overload. J Cardiovasc Pharmacol 2010;55(3):227-233.

[[48]] Schäfer C, Ladilov YV, Schääfer M, et al. Inhibition of NHE protects reoxygenated cardiomyocytes independently of anoxic Ca(2+) overload and acidosis. Am J Physiol Heart Circ Physiol 2000;279(5):H2143-H2150.

[[49]] Portal L, Morin D, Motterlini R, et al. The CO-releasing molecule CORM-3 protects adult cardiomyocytes against hypoxia-reoxygenation by modulating pH restoration. Eur J Pharmacol 2019;862:172636.

[[50]] Li A, Zheng N, Ding X. Mitochondrial abnormalities: a hub in metabolic syndrome-related cardiac dysfunction caused by oxidative stress. Heart Fail Rev 2022;27(4):1387-1394.

[[51]] Matuz-Mares D, Riveros-Rosas H, Vilchis-Landeros MM, et al. Glutathione participation in the prevention of cardiovascular diseases. Antioxidants (Basel) 2021;10(8):1220.

[[52]] Saggu G, Cortes C, Emch HN, et al. Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O). J Immunol 2013;190(12):6457-6467.

[[53]] Chen JY, Cortes C, Ferreira VP. Properdin: a multifaceted molecule involved in inflammation and diseases. Mol Immunol 2018;102:58-72.

[[54]] Domschke G, Gleissner CA. CXCL4-induced macrophages in human atherosclerosis. Cytokine 2019;122:154141.

[[55]] Jiang Z, Chen C, Yang S, et al. Contribution to the peripheral vasculopathy and endothelial cell dysfunction by CXCL4 in systemic sclerosis. J Dermatol Sci 2021;104(1):63-73.

RIGHTS & PERMISSIONS

2023 Acupuncture and Herbal Medicine